跳到正文
研踪PaperTrail

YOUR RESEARCH, IN SIGHT

让下一篇重要论文,不再错过。

覆盖计算机全学科,以 AI 为快捷入口。关注方向、作者和关键词,把发现变成持续的研究积累。

采集已暂停
正在读取账号与研究记录…

全站更新概况

+0新增论文
+0其中 AI 相关
+0已有论文修订
+0新增 AI 导读

arXiv 最近完成扫描:等待完成 · 全站最近入库:2026-11-02 00:39各信源进度 →

统计口径与数据新鲜度

统计 2026-11-03 11:06 — 2026-11-04 11:06(北京时间) · 点击数字查看对应简报;AI 相关包含在新增论文内。

最近完成检查:尚未完成最近发现新增版本:2026-11-02 00:39库内论文最新更新时间:2026-10-30 01:59

每分钟刷新已保存的数据。空检查不代表采集异常;新收录可能包含历史论文。AI 导读按新增版本计数。

8,677 已收录论文7,675 AI 相关1,866 有修订112 HF 社区发现

浏览论文库

时间范围跟随排序:版本更新、本站收录或首次发表。最新收录可能包含历史论文。

找到 1 篇论文 · 按版本更新时间排序等待首次采集
新论文 · v1arXiv:2610.37353

Cost-based variable selection for prediction models

Lasai Barreñada, Andrew Vickers, Laure Wynants, Bieke Tack, Dirk Timmerman, Ewout Steyerberg, Ben Van Calster

Objective: Variable selection for clinical prediction models is commonly done on statistical grounds related to model fit. Statistical approaches ignore the cost of misclassifications and the harm of measuring a variable. We aim to develop a decision-analytic variable selection algorithm based on net benefit. Materials and Methods: The proposed algorithm selects the set of predictors by exhaustively comparing the net benefit of all combinations using cross validation, with an extension based on backward elimination for settings with many predictors. Variables are selected if the increased net benefit from better predictiveness exceeds the net benefit reduction from the harm of variable measurement. Harm includes financial expense, time, resource allocation, and patient burden. We illustrate the algorithm through a simulated example and three real case studies. We compare its performance to traditional backward elimination and LASSO. Results: Across the case studies, parsimonious models were generated that optimized clinical utility with minimal impact on discrimination and calibration. Penalizing predictors based on their cost ensured that expensive or burdensome variables were only selected if they offer sufficient clinical utility. The algorithm was implemented in the R package NBvarsel. Discussion: Decision-analytic variable selection allows prediction models to maximize patient benefit while minimizing unnecessary clinical burden and costs. Conclusion: Clinical utility should not be an afterthought reserved only for implementation. By integrating a harm-adjusted net benefit metric directly into the variable selection process, NBvarsel allows researchers to select only the variables that sufficiently improve clinical utility.

尚无 AI 解读,展示原文摘要

stat.ME · stat.ML
arXiv ↗PDF ↗